Shareholders approved all matters at the annual general meeting, including the appointment of Davidson & Company LLP as auditor
() (OTCMKTS:LXRP) reported a successful annual general meeting Friday, noting all matters were approved, including the appointment of four directors.
The firm said directors appointed included: Chris Bunka, John Docherty, Nicholas Baxter and Ted McKechnie. The firm noted Davidson & LLP has been appointed as auditor.
READ: Lexaria Bioscience crafts new DehydraTECH innovation, files patents
The firm noted shareholders also approved executive compensation.
Lexaria has developed and out-licenses its delivery technology, which promotes healthier ingestion methods and lower overall dosing. Its DehydraTECH technology is essentially a delivery system that allows drugs and vitamins to get into the bloodstream quicker, while making them taste and smell better at the same time. The firm acquired its technology in 2014.
Lexaria's technology provides boosts in intestinal absorption rates and more rapid bloodstream delivery for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs, nicotine and other molecules.
The firm has patents pending in more than 40 countries.
Shares of Lexaria Bioscience were at C$1.10 on Friday.
Contact Katie Lewis at [email protected]
CSE:LXX
Market: CSE
Market Cap: $52.47 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Lexaria Bioscience Corp. named herein, including the promotion by the Company of Lexaria Bioscience Corp. in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Buds & Duds: Cannabis stocks hold steady; Lexaria rises on amended agreement...
The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, inched 0.2% higher at 122.9 points. Elsewhere, the OTCQX Cannabis index lost 0.2% to 489.3 points. Buds today are Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP), Curaleaf Holdings Inc...
1 week, 5 days ago
2 min read
Prev article
2 min read
